News
-
Oncosyne hosts a project seminar with Sahlgrenska to advance pancreatic cancer care
As part of the INVICTA project, Oncosyne recently hosted a project seminar with clinical collaborators from Sahlgrenska University Hospital. The meeting was held at Oslo Cancer Cluster and focused on how our tumoroid-based technology can support improved treatment outcomes for patients with pancreatic cancer. The project is progressing well and we are well on track…
-
Oncosyne is hiring an International Business Development Manager
Oncosyne is hiring, and we are now looking for an International Business Development Manager to join our team. This role will help us bring our functional precision oncology platform to new partners in pharma and biotech. The position includes developing strategies for global outreach, creating sales and presentation material, leading visibility efforts across digital channels,…
-
Poster presentation at Targets 2025 conference in Boston
Oncosyne, in collaboration with Akershus University Hospital and Institute for Molecular Medicine (Finland) present a poster at AACR-NCI-EORTC Targets.
-
Poster presentation at ESMO-GI congress 2025 in Barcelona
Oncosyne, in collaboration with Akershus University Hospital, Institute for Molecular Medicine (Finland) and Isofol Medical presented a poster at ESMO-GI.
-
Amit Roopan joins the team as a summer intern.
We welcome Amit Roopan who is joining the team as a summer intern. Amit will take on tasks spanning from software development and machine learning to laboratory assay development.
-
Nicolas Pasquier joins the team as a scientist.
We welcome PhD Nicolas Pasquier who is joining the Oncosyne team as a scientist.
-
Visit from the Norwegian Cancer Society.
Jarle Bruun presented Oncosyne’s lab facilities at Oslo Cancer Cluster Incubator.
-
Expansion into pancreatic cancer
The first pancreatic cancer samples were received from Sahlgrenska University Hospital in Sweden.
-
Poster presentation at 36th EORTC-NCI-AACR symposium in Barcelona
We are thrilled to announce that Isofol Medical, Ahus, and Oncosyne got a late-breaking abstract accepted for poster presentation at the 36th EORTC-NCI-AACR symposium in Barcelona later this month.
-
We are hiring!
The coming year, we will validate our in vitro diagnostic test, expand to new disease indications and leverage our platform for drug development projects.
-
Oncosyne presents poster at ELRIG UK Drug Discovery 2024
Oncosyne and collaborators presented a poster at the ELRIG UK Drug Discovery 2024 conference in London.
-
Professor Åke Andrén-Sandberg is joining the team as a clinical advisor
Professor Åke Andrén-Sandberg is joining the team as a clinical advisor.
-
Initiating development of Oncosyne’s next-generation in vitro diagnostic test for pancreatic cancer
Hybrid Technology Hub and Oncosyne held a kickoff meeting initiating development of Oncosyne’s next-generation in vitro diagnostic test for pancreatic cancer.
-
Oncosyne presented at GoWest – Nordic Venture Capital Forum in Gothenburg
Oncosyne presented at GoWest – Nordic Venture Capital Forum in Gothenburg. Through collaborators, customers, and providers, Oncosyne is building connections to the thriving biotech ecosystem in Västra Götaland.
-
In vitro diagnostic drug testing for pancreatic cancer granted MNOK 16 in support
Our project for in vitro diagnostic drug testing for pancreatic cancer was granted MNOK 16 in support through the Innovation Project for the Industrial Sector program
-
Oncosyne’s CEO interviewed on MedWatch
MedWatch publishes an interview with CEO Jarle Bruun outlining company background, status and future plans.
-
Oncosyne featured in Radium podcast
Oncosyne’s Jarle Bruun and Peter W. Eide guest the Radium podcast.
-
Oncosyne finishes research and development project paving way for clinical validation
Oncosyne finishes a research and development project paving way for clinical validation.
-
Status on recruitment for the Tailoring Treatment in Colorectal Cancer
Recruitment for the Tailoring Treatment in Colorectal Cancer study is at 100% of the initial target of 40 patients.
-
Isofol Medical annonces collaboration with Oncosyne
Pharmaceutical company Isofol Medical announces a collaboration with Oncosyne.
-
Oncosyne Pipeline Update January 2023
Oncosyne moves its pipeline into a dedicated laboratory space at Oslo Cancer Cluster Incubator.
-
Oncosyne receives funding through Eurostars-3
Oncosyne, Akershus University Hospital, and CTC receive funding through the Eurostars-3 joint programme.
-
Update on Tailoring Treatment in Colorectal Cancer recruitment
Recruitment for the Tailoring Treatment in Colorectal Cancer (TargetCRC) study is 50% completed and on schedule.
-
Oncosyne presented at Rising Stars
Oncosyne presented at the Rising Stars session at the Nordic Life Science (NLS) Days in Malmö 28-29th September.
-
Minister of Trade and Industry visits Oncosyne’s laboratories
In connection with visiting the Oslo Cancer Cluster Innovation Park, the Minister of Trade and Industry received a brief presentation in Oncosyne’s laboratories.
-
Patient-derived microtumors growing in the lab
2022-May Patient-derived microtumors are growing in the lab. These are indispensable for finalizing our diagnostic platform.
-
Oncosyne lands first investment round financing development towards the registrational clinical trial
Oncosyne lands its first investment round financing development towards the registrational clinical trial.
-
Oncosyne’s Jarle Bruun and Peter W. Eide guests on Radium podcast
Oncosyne’s Jarle Bruun and Peter W. Eide guest the Radium podcast
-
Member of Parliament visited the Oslo Cancer Cluster Incubator and Oncosyne’s laboratories.
Tone W. Trøen visited the Oslo Cancer Cluster Incubator and Oncosyne’s laboratories.
-
Oncosyne recieves generous grant from Regionale Forskningsfond Oslo
Oncosyne recieves a generous grant from Regionale Forskningsfond Oslo for clinical research and development of our diagnostic test platform.
-
M.Sc. Christer Anker Andreassen joins the team as product developer
We welcome M.Sc. Christer Anker Andreassen who is joining the team as product developer! Mr. Andreassen will help finalizing our platform for clinical studies
-
Oncosyne finishes successful research collaboration with Dr. Teijo Pellinen at FIMM
Oncosyne finishes a successful research collaboration with Dr. Teijo Pellinen at FIMM.
-
Oncosyne moves into OCCI’s shining laboratories
2021-Jun Oncosyne moves into OCCI’s shining laboratories. We are excited to become a part of this ambitious, dynamic growth environment